MALANG KOTA – Salah satu bentuk kepedulian Kapolresta Malang Kota,Kombes Pol Budi Hermanto memfasilitasi relawan dalam kegiatan sehari – hari agar aman dalam berkendara roda dua,kali ini Polresta Malang Kota memberikan helm SNI ( Standart Nasional Indonesia).
Pemberian helm SNI oleh Kapolresta Malang Kota kepada relawan Kota Malang kali ini juga sebagai bentuk kampanye pada Operasi Keselamatan Semeru 2022 untuk disiplin berlalulintas.
Hal tersebut seperti diungkapkan oleh Kapolresta Malang Kota Kombes Pol Budi Hermanto melalui Kasi Humas Polresta Malang Kota Ipda Eko Novi saat mendampingi Kasat lantas Polresta Malang Kota Kompol Yoppy Anggi Khrisna menyerahkan Helm SNI kepada para relawan yang hadir, Senin (7/3/22).
“Ini merupakan upaya Polresta Malang Kota dalam mendorong tercapainya kualitas hidup masyarakat yang lebih baik seperti terbinanya masyarakat yang sehat, aman dan bermoral di jalan raya,”kata Ipda Novi.
Menurut Ipda Novi, ada 16 orang relawan yang mendapatkan Helm SNI diantaranya dari unsur pengaduan publik, relawan anak bangsa, relawan pendamping difabel dan relawan covid hunter.
“Para relawan ini berperan tidak hanya tertib berlalu lintas untuk diri sendiri, tetapi juga melakukan edukasi kepada masyarakat sekitarnya dalam memastikan agar masyarakat juga mematuhi lalu lintas bahkan termasuk patuh Prokes dalam upaya penganganan Covid – 19,”tambah Ipda Novi.
Sementara itu usai kegiatan pembagian Helm SNI, Kasatlantas Polresta Malang Kota Kompol Yoppy Anggi Khrisna mengatakan, kegiatan dalam rangka Operasi Keselematan semeru 2022 kali ini Polresta Malang Kota ingin memelihara kemitraan dengan elemen masyarakat yang selama ini sudah terjalin.
“Ini upaya kami, Polresta Malang Kota dalam pelayanan yang berorientasi masyarakat dengan mengedepankan dan mengutamakan pendekatan proactive problem solving dan partnership,”jelas Kompol Yoppy
Kasatlantas Polresta Malang Kota juga mengungkapkan untuk terwujudnya kolaborasi tersebut pihakanya mengawali dengan cara pandang serta nilai – nilai masyarakat lokal dalam menyelesaikan isu bersama yang jadi perhatian masyarakat dan Polisi, dalam konteks ini, kelengkapan berkendaraan menjadi entry point.
“Dengan demikian, problem solving approach sebagai pendekatan community Oriented Policing merupakan sebuah pendekatan dalam memperkuat kapasitas masyarakat itu sendiri termasuk nilai – nilai citizenship,”tambah Kompol Yoppy
Kompol Yoppy berharap semoga perewakilan relawan yang hadir menerima helm kali ini dapat menjadi sumber inspirasi dan motivasi bagi yang lain.
“Harapan kami rekan – rekan relawan dapat senantiasa membudayakan tertib berlalulintas di jalan raya,dan menjadi contoh masyarakat yang lain,”pugkas Kasatlantas Polresta Malang Kota.
Sementara itu perwakilan relawan yang hadir menyampaikan ucapan terimakasih dan apresiasi kepada pihak Polresta Malang Kota yang menginisiasi acara tersebut.
“Kami perwakilan relawan mengucapkan terimakasih sekaligus apresiasi kepada bapak Kapolresta dan bapak Kasatlantas yang telah mengundang kami untuk di berikan helm, kami sepakat dan mendukung kebijakan Polresta Malang Kota dalam rangka mewujudkan ketertiban di masyarakat sehingga dapat meningkatkan daya dukung dan daya guna untuk meningkatkan kualitas hidup bermasyarakat di Kota Malang” pungkas Sudarno. (**19/humas)
COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.
The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]
COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]
Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]
Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.
COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.
The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]
COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]
Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]
Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.